financetom
Business
financetom
/
Business
/
Prosthetics maker Ottobock plans to raise $941 million in German IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Prosthetics maker Ottobock plans to raise $941 million in German IPO
Oct 7, 2025 11:59 AM

Oct 7 (Reuters) - German prosthetics company Ottobock

said on Tuesday it plans to raise about 807 million euros

($941.4 million) by pricing its planned initial public offering

(IPO) at 66 euros per share.

The world's largest manufacturer of artificial limbs said

that it will sell around 12.24 million shares at the upper end

of its previously announced price range of 62-66 euros.

The firm said it expects a valuation of 4.2 billion euros at

this pricing.

The company plans to list on the Frankfurt stock exchange on

October 9.

($1 = 0.8573 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Six Flags Reaffirms Outlook As Attendance Strengthens And Season Pass Sales Accelerate
Six Flags Reaffirms Outlook As Attendance Strengthens And Season Pass Sales Accelerate
Sep 12, 2025
Six Flags Entertainment Corporation ( FUN ) shares climbed Friday after the operator outlined improving summer traffic and robust demand heading into the Halloween and winter holiday periods. The company, the largest regional amusement park operator in North America, issued a late-summer attendance update covering performance through Labor Day. The company said it welcomed 17.8 million guests over the nine...
Exclusive-AstraZeneca pauses $270 million investment in Britain
Exclusive-AstraZeneca pauses $270 million investment in Britain
Sep 12, 2025
LONDON (Reuters) - Britain's biggest company AstraZeneca ( AZN ) has paused a planned 200 million pound ($271.26 million) investment in its Cambridge research site, a spokesperson said, the latest drugmaker to retreat from Britain. The decision on the investment, which had been set to create 1,000 jobs, means none of AstraZeneca's ( AZN ) planned new funding - originally...
Cathie Wood Says Yes To Klarna IPO: Ark Invest Scoops Up Shares On First Two Days Of Trading
Cathie Wood Says Yes To Klarna IPO: Ark Invest Scoops Up Shares On First Two Days Of Trading
Sep 12, 2025
Ark Invest CEO Cathie Wood, known for investing in high growth companies that are innovative, is betting on Klarna Group ( KLAR )‘s future growth in the buy now, pay later sector. Daily email notifications from Ark Invest show the company bought shares of Klarna ( KLAR ) in its first two days of being a public company. The IPO...
Scholar Rock's Apitegromab Expected to Get Approval With Broad Label in US, Truist Says
Scholar Rock's Apitegromab Expected to Get Approval With Broad Label in US, Truist Says
Sep 12, 2025
12:45 PM EDT, 09/12/2025 (MT Newswires) -- Scholar Rock ( SRRK ) has a 50% to 60% chance of getting US approval with a broad label for its apitegromab drug candidate for spinal muscular atrophy by the target action date of Sept. 22, Truist Securities said in a note Friday. A modest delay of about one quarter is also possible...
Copyright 2023-2026 - www.financetom.com All Rights Reserved